Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing
- PMID: 22020387
- PMCID: PMC4336783
- DOI: 10.1038/nbt.1996
Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing
Abstract
We describe an approach for targeted genome resequencing, called oligonucleotide-selective sequencing (OS-Seq), in which we modify the immobilized lawn of oligonucleotide primers of a next-generation DNA sequencer to function as both a capture and sequencing substrate. We apply OS-Seq to resequence the exons of either 10 or 344 cancer genes from human DNA samples. In our assessment of capture performance, >87% of the captured sequence originated from the intended target region with sequencing coverage falling within a tenfold range for a majority of all targets. Single nucleotide variants (SNVs) called from OS-Seq data agreed with >95% of variants obtained from whole-genome sequencing of the same individual. We also demonstrate mutation discovery from a colorectal cancer tumor sample matched with normal tissue. Overall, we show the robust performance and utility of OS-Seq for the resequencing analysis of human germline and cancer genomes.
Figures



References
-
- Shendure J, et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science. 2005;309:1728–1732. - PubMed
-
- Albert TJ, et al. Direct selection of human genomic loci by microarray hybridization. Nat. Methods. 2007;4:903–905. - PubMed
-
- Hodges E, et al. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 2007;39:1522–1527. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous